NASDAQ : AVR

Anteris Technologies Global Corp. — Key statistics

Healthcare · Medical Instruments & Supplies · Australia

Last price 6.31 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 615.18M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Key statistics

Valuation

MeasureValue
Market Cap566.92M
Enterprise Value313.38M

Dates

MeasureValue
Earnings DateNov 16, 2026
Ex-Dividend Daten/a

Shares

MeasureValue
Current Share Class97.49M
Shares Outstanding97.49M
Shares Change (YoY)+120.35%
Shares Change (QoQ)+17.26%
Owned by Insiders (%)0.91%
Owned by Institutions (%)57.77%
Float68.50M

Ratios

MeasureValue
PE Ration/a
Forward PEn/a
PS Ratio249.82
Forward PS50.88
PB Ratio2.45
P/TBV Ratio2.23
P/FCF Ration/a
P/OCF Ration/a
PEG Ration/a

Evratios

MeasureValue
EV / Earningsn/a
EV / Sales136.73
EV / EBITDAn/a
EV / EBITn/a
EV / FCFn/a

Financialposition

MeasureValue
Current Ratio14.20
Quick Ratio14.02
Debt / Equity0.01
Debt / EBITDAn/a
Debt / FCFn/a
Interest Coverage-580.51

Financialefficiency

MeasureValue
Return on Equity (ROE)-74.65%
Return on Assets (ROA)-42.51%
Return on Invested Capital (ROIC)-47.12%
Return on Capital Employed (ROCE)-41.80%
Weighted Average Cost of Capital (WACC)8.22%
Revenue Per Employee$12,885
Profits Per Employee-$595,195
Employee Count174
Asset Turnover0.01
Inventory Turnover2.46

Taxes

MeasureValue
Income Tax492,000
Effective Tax Raten/a

Stockprice

MeasureValue
Beta (5Y)0.73
52-Week Price Change+28.73%
50-Day Moving Average7.49
200-Day Moving Average7.39
Relative Strength Index (RSI)33.30
Average Volume (20 Days)1,674,928

Shortselling

MeasureValue
Short Interest7.93M
Short Previous Month6.67M
Short % of Shares Out8.14%
Short % of Float11.58%
Short Ratio (days to cover)6.50

Incomestatement

MeasureValue
Revenue2.24M
Gross Profit1.68M
Operating Income-106.23M
Pretax Income-102.42M
Net Income-103.56M
EBITDA-104.50M
EBIT-106.23M
Loss Per Share-$1.62

Balancesheet

MeasureValue
Cash & Cash Equivalents256.87M
Total Debt3.32M
Net Cash253.55M
Net Cash Per Share$2.60
Equity (Book Value)251.67M
Book Value Per Share2.58
Working Capital242.29M

Cashflow

MeasureValue
Operating Cash Flow-86.26M
Capital Expenditures-1.95M
Depreciation & Amortization1.74M
Net Borrowing-1.26M
Free Cash Flow-88.21M
FCF Per Share-$0.90

Margins

MeasureValue
Gross Margin74.98%
Operating Margin-4,738.36%
Pretax Margin-4,568.02%
Profit Marginn/a
EBITDA Marginn/a
EBIT Marginn/a
FCF Marginn/a

Dividends

MeasureValue
Dividend Per Sharen/a
Dividend Yieldn/a
Dividend Growth (YoY)n/a
Years of Dividend Growthn/a
Payout Ration/a
FCF Payout Ration/a
Buyback Yield-120.35%
Shareholder Yield-120.35%
Earnings Yield-27.83%
FCF Yield-15.75%

Analystforecasts

MeasureValue
Price Target$14.00
Price Target Difference140.76%
Analyst ConsensusStrong Buy
Analyst Count5
Revenue Growth Forecast (3Y)104.29%
EPS Growth Forecast (3Y)n/a

Stocksplits

MeasureValue
Last Split Daten/a
Split Typen/a
Split Ration/a

Scores

MeasureValue
Altman Z-Score8.77
Piotroski F-Score3

Fairvalue

MeasureValue
Lynch Fair Valuen/a
Lynch Upsiden/a
Graham Numbern/a
Graham Upsiden/a